Jonathan Lu

1.1k total citations
23 papers, 957 citations indexed

About

Jonathan Lu is a scholar working on Immunology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jonathan Lu has authored 23 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jonathan Lu's work include Atherosclerosis and Cardiovascular Diseases (10 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Lipoproteins and Cardiovascular Health (5 papers). Jonathan Lu is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (10 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Lipoproteins and Cardiovascular Health (5 papers). Jonathan Lu collaborates with scholars based in United States, Taiwan and Japan. Jonathan Lu's co-authors include Chu‐Huang Chen, Tatsuya Sawamura, Liang‐Yin Ke, Chih‐Sheng Chu, Philip D. Henry, Chao-Yuh Yang, Jeffrey P. Walterscheid, Daming Tang, Chao-Yuh Yang and Chih-Chieh Chen and has published in prestigious journals such as Circulation, Blood and PLoS ONE.

In The Last Decade

Jonathan Lu

23 papers receiving 942 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Lu United States	17	479	342	243	192	156	23	957
Po‐Yuan Chang Taiwan	21	251 0.5×	284 0.8×	329 1.4×	129 0.7×	123 0.8×	43	1.0k
Yoshiaki Tsukamoto Japan	10	337 0.7×	303 0.9×	129 0.5×	146 0.8×	248 1.6×	14	823
J. H. Qiao United States	11	695 1.5×	425 1.2×	483 2.0×	156 0.8×	98 0.6×	20	1.5k
Ellen Knutsen Rydberg Sweden	5	404 0.8×	287 0.8×	298 1.2×	152 0.8×	49 0.3×	6	916
Dale Newland United States	10	350 0.7×	543 1.6×	425 1.7×	109 0.6×	177 1.1×	14	1.2k
S. Imes United States	4	379 0.8×	276 0.8×	219 0.9×	85 0.4×	172 1.1×	5	927
Akemi Kakino Japan	17	591 1.2×	174 0.5×	473 1.9×	103 0.5×	94 0.6×	35	1.2k
Melba Hernandez United States	14	356 0.7×	463 1.4×	429 1.8×	196 1.0×	43 0.3×	15	1.2k
Sònia Benı́tez Spain	24	636 1.3×	727 2.1×	375 1.5×	269 1.4×	275 1.8×	67	1.6k

Countries citing papers authored by Jonathan Lu

Since Specialization

Citations

This map shows the geographic impact of Jonathan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Lu more than expected).

Fields of papers citing papers by Jonathan Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Lu. The network helps show where Jonathan Lu may publish in the future.

Co-authorship network of co-authors of Jonathan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Lu. A scholar is included among the top collaborators of Jonathan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Lu. Jonathan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Jonathan, et al.. (2024). Impact of controlled ice nucleation on intracellular dehydration, ice formation and their implications on T cell freeze–thaw viability. International Journal of Pharmaceutics. 665. 124694–124694. 2 indexed citations

Preston, Ioana R., David B. Badesch, Hossein Ardeschir Ghofrani, et al.. (2021). Abstract 10188: Sotatercept Phase 3 Program Design and Rationale: A Novel Treatment for Pulmonary Arterial Hypertension. Circulation. 144(Suppl_1). 3 indexed citations

Ma, Yanzhuo, Nancy Cheng, Junping Sun, et al.. (2020). Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation. Lipids in Health and Disease. 19(1). 189–189. 5 indexed citations

Lee, An‐Sheng, Shih‐Sheng Chang, Chia‐Ming Chang, et al.. (2020). Detection of a High Ratio of Soluble to Membrane‐Bound LOX‐1 in Aspirated Coronary Thrombi From Patients With ST‐Segment–Elevation Myocardial Infarction. Journal of the American Heart Association. 9(2). e014008–e014008. 18 indexed citations

Shen, Ming‐Yi, Jing‐Fang Hsu, Fang-Yu Chen, et al.. (2019). Combined LDL and VLDL Electronegativity Correlates with Coronary Heart Disease Risk in Asymptomatic Individuals. Journal of Clinical Medicine. 8(8). 1193–1193. 14 indexed citations

Teng, Renli, et al.. (2018). Pharmacokinetics and pharmacodynamics of ticagrelor in subjects on hemodialysis and subjects with normal renal function. European Journal of Clinical Pharmacology. 74(9). 1141–1148. 6 indexed citations

Lee, An‐Sheng, Long‐Sheng Lu, Liang‐Yin Ke, et al.. (2018). Human electronegative LDL induces mitochondrial dysfunction and premature senescence of vascular cells in vivo. Aging Cell. 17(4). e12792–e12792. 47 indexed citations

Zhaorigetu, Siqin, Henry Bair, Jonathan Lu, et al.. (2017). Perturbations in Endothelial Dysfunction-Associated Pathways in the Nitrofen-Induced Congenital Diaphragmatic Hernia Model. Journal of Vascular Research. 55(1). 26–34. 16 indexed citations

Akyol, Sümeyya, Jonathan Lu, Ömer Akyol, et al.. (2016). The role of electronegative low-density lipoprotein in cardiovascular diseases and its therapeutic implications. Trends in Cardiovascular Medicine. 27(4). 239–246. 24 indexed citations

10.

Lu, Jonathan, Akshay Bagai, Chris Buller, et al.. (2015). Incidence and characteristics of inappropriate and false-positive cardiac catheterization laboratory activations in a regional primary percutaneous coronary intervention program. American Heart Journal. 173. 126–133. 15 indexed citations

11.

Chen, Chih-Chieh, Liang‐Yin Ke, Chih‐Sheng Chu, et al.. (2015). Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis. Clinical Chemistry. 62(2). 320–327. 107 indexed citations

12.

Hsu, Jing‐Fang, Tzu‐Chieh Chou, Jonathan Lu, et al.. (2014). Low-Density Lipoprotein Electronegativity Is a Novel Cardiometabolic Risk Factor. PLoS ONE. 9(9). e107340–e107340. 24 indexed citations

13.

Chu, Chih‐Sheng, Long‐Sheng Lu, Brian Walton, et al.. (2013). Electronegative Low-Density Lipoprotein Increases C-Reactive Protein Expression in Vascular Endothelial Cells through the LOX-1 Receptor. PLoS ONE. 8(8). e70533–e70533. 41 indexed citations

14.

Chang, Po‐Yuan, Fu‐Hsiung Chang, Jonathan Lu, et al.. (2013). Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarction. Cardiovascular Research. 99(1). 137–145. 49 indexed citations

15.

Chen, Chu‐Huang, Jonathan Lu, Shuhua Chen, et al.. (2012). Effects of Electronegative VLDL on Endothelium Damage in Metabolic Syndrome. Diabetes Care. 35(3). 648–653. 31 indexed citations

16.

Ke, Liang‐Yin, David Engler, Jonathan Lu, et al.. (2011). Chemical composition-oriented receptor selectivity of L5, a naturally occurring atherogenic low-density lipoprotein. Pure and Applied Chemistry. 83(9). 1731–1740. 33 indexed citations

17.

Lu, Jonathan, Junhai Yang, Alan R. Burns, et al.. (2009). Mediation of Electronegative Low-Density Lipoprotein Signaling by LOX-1. Circulation Research. 104(5). 619–627. 113 indexed citations

18.

Tang, Daming, Jonathan Lu, Jeffrey P. Walterscheid, et al.. (2007). Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1. Journal of Lipid Research. 49(1). 33–47. 68 indexed citations

19.

Chen, Chu‐Huang, Simon M. Poucher, Jonathan Lu, & Philip D. Henry. (2004). Fibroblast Growth Factor 2: From Laboratory Evidence to Clinical Application. Current Vascular Pharmacology. 2(1). 33–43. 57 indexed citations

20.

Chen, Chu‐Huang, Tao Jiang, Wei Jiang, et al.. (2003). Low-Density Lipoprotein in Hypercholesterolemic Human Plasma Induces Vascular Endothelial Cell Apoptosis by Inhibiting Fibroblast Growth Factor 2 Transcription. Circulation. 107(16). 2102–2108. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact